Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
Authors
Keywords
SARS-CoV-2, Spike protein, MRNA, Nucleoside-modified, LNP, vaccines
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 142, Issue -, Pages 111953
Publisher
Elsevier BV
Online
2021-07-23
DOI
10.1016/j.biopha.2021.111953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
- (2021) Xuhua Xia Viruses-Basel
- Cationic lipids for gene delivery: many players, one goal
- (2021) Federica Ponti et al. CHEMISTRY AND PHYSICS OF LIPIDS
- BNT162b2 mRNA COVID-19 Vaccine: First Approval
- (2021) Yvette N. Lamb DRUGS
- mRNA vaccine: a potential therapeutic strategy
- (2021) Yang Wang et al. Molecular Cancer
- Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype
- (2021) Steve Pascolo Viruses-Basel
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- The dawn of mRNA vaccines: The COVID-19 case
- (2021) Rein Verbeke et al. JOURNAL OF CONTROLLED RELEASE
- The challenge and prospect of mRNA therapeutics landscape
- (2020) Yuhua Weng et al. BIOTECHNOLOGY ADVANCES
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery
- (2020) Yulia Eygeris et al. NANO LETTERS
- The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
- (2020) Jieliang Wang et al. AAPS PHARMSCITECH
- Recent advances in mRNA vaccine technology
- (2020) Norbert Pardi et al. CURRENT OPINION IN IMMUNOLOGY
- Lessons for COVID-19 Immunity from Other Coronavirus Infections
- (2020) Alan Sariol et al. IMMUNITY
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- Controlling the SARS-CoV-2 spike glycoprotein conformation
- (2020) Rory Henderson et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
- (2020) Ahmed O. Hassan et al. CELL
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
- (2020) Shuqin Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COVID-19 and mRNA Vaccines—First Large Test for a New Approach
- (2020) Jennifer Abbasi JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nanomedicine-Based Approaches for mRNA Delivery
- (2020) Satoshi Uchida et al. MOLECULAR PHARMACEUTICS
- All eyes on a hurdle race for a SARS-CoV-2 vaccine
- (2020) Christian Gaebler et al. NATURE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
- (2020) M. Alejandra Tortorici et al. SCIENCE
- The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV
- (2020) Mihkel Örd et al. Scientific Reports
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
- (2020) Iman M. Alfagih et al. Pharmaceutics
- The known unknowns of T cell immunity to COVID-19
- (2020) Annika C. Karlsson et al. Science Immunology
- COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies
- (2020) Kajal Rawat et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
- (2019) Giulietta Maruggi et al. MOLECULAR THERAPY
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
- (2019) Kimberly J. Hassett et al. Molecular Therapy-Nucleic Acids
- A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
- (2019) Markus Baiersdörfer et al. Molecular Therapy-Nucleic Acids
- mRNA structure regulates protein expression through changes in functional half-life
- (2019) David M. Mauger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
- (2019) Sergio Linares-Fernández et al. TRENDS IN MOLECULAR MEDICINE
- Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells
- (2019) Marco Maugeri et al. Nature Communications
- Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
- (2018) Norbert Pardi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma
- (2018) Yuhua Wang et al. MOLECULAR THERAPY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Maximizing the translational yield of mRNA therapeutics by minimizing 5'-UTRs
- (2018) Zeljka Trepotec et al. TISSUE ENGINEERING PART A
- Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
- (2018) Sriram Vaidyanathan et al. Molecular Therapy-Nucleic Acids
- Post-transcriptional pseudouridylation in mRNA as well as in some major types of noncoding RNAs
- (2018) Hironori Adachi et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening
- (2018) Alexandra G. Orlandini von Niessen et al. MOLECULAR THERAPY
- Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
- (2018) Nuphar Veiga et al. Nature Communications
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- Short poly(A) tails are a conserved feature of highly expressed genes
- (2017) Sarah Azoubel Lima et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
- (2017) Jesper Pallesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type I Interferons Modulate CD8 + T Cell Immunity to mRNA Vaccines
- (2017) Ans De Beuckelaer et al. TRENDS IN MOLECULAR MEDICINE
- Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
- (2017) Giulietta Maruggi et al. VACCINE
- Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
- (2017) Norbert Pardi et al. Nature Communications
- Short poly(A) tails are a conserved feature of highly expressed genes
- (2017) Sarah Azoubel Lima et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Understanding RNA modifications: the promises and technological bottlenecks of the ‘epitranscriptome’
- (2017) Matthias Schaefer et al. Open Biology
- A thermostable messenger RNA based vaccine against rabies
- (2017) Lothar Stitz et al. PLoS Neglected Tropical Diseases
- The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
- (2016) Xinwei Cheng et al. ADVANCED DRUG DELIVERY REVIEWS
- Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice
- (2016) Abderraouf Selmi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Evading innate immunity in nonviral mRNA delivery: don’t shoot the messenger
- (2016) Joke Devoldere et al. DRUG DISCOVERY TODAY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- mRNA capping: biological functions and applications
- (2016) Anand Ramanathan et al. NUCLEIC ACIDS RESEARCH
- Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, andToxoplasma gondiichallenges with a single dose
- (2016) Jasdave S. Chahal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences
- (2016) Alexandra E Grier et al. Molecular Therapy-Nucleic Acids
- N 1 -methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
- (2015) Oliwia Andries et al. JOURNAL OF CONTROLLED RELEASE
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- Lipid-based mRNA vaccine delivery systems
- (2014) Patrick Midoux et al. Expert Review of Vaccines
- Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells
- (2014) Thomas M. Carlile et al. NATURE
- Toxicity profiling of several common RNAi-based nanomedicines: a comparative study
- (2013) Dalit Landesman-Milo et al. Drug Delivery and Translational Research
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
- (2012) Muthusamy Jayaraman et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
- Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
- (2011) M Diken et al. GENE THERAPY
- Liposome based systems for systemic siRNA delivery: Stability in blood sets the requirements for optimal carrier design
- (2011) Kevin Buyens et al. JOURNAL OF CONTROLLED RELEASE
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
- (2011) B. R. Anderson et al. NUCLEIC ACIDS RESEARCH
- Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway
- (2011) Christina Lorenz et al. RNA Biology
- Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems
- (2010) Deepa Mohanan et al. JOURNAL OF CONTROLLED RELEASE
- Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting
- (2010) Shyh-Dar Li et al. JOURNAL OF CONTROLLED RELEASE
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity
- (2010) Mariola Fotin-Mleczek et al. JOURNAL OF IMMUNOTHERAPY
- Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5
- (2008) Hiroki Kato et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search